Leiden, Netherlands

Johannes L Bos

This inventor holds 3 USPTO granted patents. Top assignee: The Board of Rijks Universiteit Leiden. Active years: 1989-1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Johannes L Bos. Retrieved from https://idiyas.com/inventor/johannes-l-bos

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 3

Forward Citations = 66(Granted Patents)


Company Filing History:


Years Active: 1989-1998

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Johannes L Bos

Introduction

Johannes L Bos is a prominent inventor based in Leiden, Netherlands. He has made significant contributions to the field of molecular biology, particularly in the detection of activated RAS oncogenes. With a total of 3 patents, his work has implications for cancer research and diagnostics.

Latest Patents

Bos's latest patents include innovative methods for detecting activated RAS oncogenes. One of his notable inventions involves molecules that are complementary to nucleotide sequences encoding mutant ras proteins. These proteins contain a single-base mutation in the codon encoding amino acids at positions 13, 12, or 61. The molecules he developed are useful in detecting specific single-base mutations in altered ras genes, which are associated with various cancers.

Career Highlights

Johannes L Bos is affiliated with the Board of Rijks Universiteit Leiden, where he continues to advance research in his field. His work has garnered attention for its potential to improve cancer detection and treatment strategies.

Collaborations

Some of his notable coworkers include Alex Jan Van Der Eb and Alex J Van Der Eb, who have collaborated with him on various research projects.

Conclusion

Johannes L Bos's contributions to the detection of activated RAS oncogenes highlight his role as an influential inventor in molecular biology. His innovative approaches have the potential to significantly impact cancer diagnostics and treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…